Mixed Autoimmune Hemolytic Anemia With Refractory Cold Agglutinin Syndrome in a Child Successfully Treated With Serial Whole Blood Exchange Transfusions and Immunosuppression

J Pediatr Hematol Oncol. 2026 Apr 1;48(3):e128-e133. doi: 10.1097/MPH.0000000000003180. Epub 2026 Mar 2.

Abstract

Background: Mixed autoimmune hemolytic anemia can manifest with severe intra- and extravascular hemolysis, with autoagglutination contributing to vaso-occlusive microangiopathic phenomena.

Observations: We present a case of mixed autoimmune haemolytic anemia with unusually severe cold agglutinin syndrome causing cutaneous, cerebral, ocular, and aural manifestations of microvasculopathy and massive intravascular haemolysis, requiring 6 double-volume whole-blood exchanges over 8 days to temporise severe hemolysis and autoagglutination while immunosuppression with high-dose steroids, rituximab, and bortezomib took effect.

Conclusions: Whole-blood exchange permitted fluid-neutral clearance of preformed antibodies and antibody-coated red cells, with dramatic resolution of microvasculopathy and hemolysis, before discharge home on oral steroid therapy.

Keywords: cold agglutinin; hemolytic anemia; paediatric; whole blood exchange.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • Anemia, Hemolytic, Autoimmune* / pathology
  • Anemia, Hemolytic, Autoimmune* / therapy
  • Bortezomib / administration & dosage
  • Bortezomib / therapeutic use
  • Exchange Transfusion, Whole Blood* / methods
  • Female
  • Humans
  • Immunosuppression Therapy* / methods
  • Immunosuppressive Agents* / therapeutic use
  • Male
  • Rituximab / administration & dosage
  • Rituximab / therapeutic use

Substances

  • Immunosuppressive Agents
  • Rituximab
  • Bortezomib